drugset / Trial / NCT00005773

Early Inhaled Nitric Oxide for Respiratory Failure in Newborns

NCT00005773 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This prospective, randomized controlled trial tested whether initiating iNO therapy earlier would reduce death and reduce the use of extracorporeal membrane oxygenation (ECMO) -- temporary lung bypass -- therapy compared with the standard recommendation threshold. Infants who were born at \>34 weeks' gestation were enrolled when they required assisted ventilation and had an oxygenation index (OI) \>15 and \<25 on any 2 measurements in a 12-hour interval. Infants were randomized to receive either early iNO or to simulated initiation of iNO (control). Infants who had an increase in OI to 25 or more were given iNO as standard therapy. The neurodevelopment of the subjects were evaluated at 18-22 months corrected age.

Timeline

Start
1998-08
Primary completion
2001-05
Completion
2003-08

Outcome

Missed primary endpoint

Stopped (Enrollment): “Halted after 3 years because of a persistent decline in enrollment”

paper does not reduce the incidence of ECMO/mortality when initiated at an OI of 15 to 25 compared with initiation at >25 PMID 14993550 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitric Oxide Other / unclassified 20 ppm Inhaled